Free Trial

agilon health (AGL) Stock Price, News & Analysis

$3.52
-0.35 (-9.04%)
(As of 09/20/2024 ET)

About agilon health Stock (NYSE:AGL)

Key Stats

Today's Range
$3.48
$3.92
50-Day Range
$3.21
$7.52
52-Week Range
$3.07
$20.37
Volume
5.25 million shs
Average Volume
4.99 million shs
Market Capitalization
$1.45 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.57
Consensus Rating
Hold

Company Overview

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

agilon health Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks

Overall MarketRank™: 42nd Percentile

agilon health scored higher than 42% of companies evaluated by MarketBeat, and ranked 738th out of 1,007 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    agilon health has received a consensus rating of Hold. The company's average rating score is 2.16, and is based on 4 buy ratings, 14 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    agilon health has only been the subject of 4 research reports in the past 90 days.

  • Read more about agilon health's stock forecast and price target.
  • Earnings Growth

    Earnings for agilon health are expected to grow in the coming year, from ($0.32) to ($0.15) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of agilon health is -5.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of agilon health is -5.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    agilon health has a P/B Ratio of 2.16. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about agilon health's valuation and earnings.
  • Percentage of Shares Shorted

    13.59% of the float of agilon health has been sold short.
  • Short Interest Ratio / Days to Cover

    agilon health has a short interest ratio ("days to cover") of 9.
  • Change versus previous month

    Short interest in agilon health has recently increased by 6.33%, indicating that investor sentiment is decreasing significantly.
  • Percentage of Shares Shorted

    13.59% of the float of agilon health has been sold short.
  • Short Interest Ratio / Days to Cover

    agilon health has a short interest ratio ("days to cover") of 9.
  • Change versus previous month

    Short interest in agilon health has recently increased by 6.33%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    agilon health has a news sentiment score of 0.68. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.48 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 10 news articles for agilon health this week, compared to 6 articles on an average week.
  • Search Interest

    Only 9 people have searched for AGL on MarketBeat in the last 30 days. This is a decrease of -18% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added agilon health to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, agilon health insiders have bought more of their company's stock than they have sold. Specifically, they have bought $67,200.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 3.20% of the stock of agilon health is held by insiders.

  • Read more about agilon health's insider trading history.
Receive AGL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for agilon health and its competitors with MarketBeat's FREE daily newsletter.

AGL Stock News Headlines

agilon health, inc. (NYSE:AGL) Sees Large Increase in Short Interest
Are You Ready for a Small-Cap Rally?
Jeff Bezos has just made a bold move into Quantum Computing as a Service (QaaS), a technology set to disrupt industries worth over $46 trillion. What's even more intriguing?
agilon health (NYSE:AGL) Shares Gap Up Following Insider Buying Activity
Insider Stock Buying Reaches US$815.1k On agilon health
agilon health, inc. (NYSE:AGL) CEO Steven Sell Acquires 20,000 Shares
AGL Dec 2025 5.000 call
See More Headlines

AGL Stock Analysis - Frequently Asked Questions

agilon health's stock was trading at $12.55 at the beginning of the year. Since then, AGL shares have decreased by 72.0% and is now trading at $3.52.
View the best growth stocks for 2024 here
.

agilon health, inc. (NYSE:AGL) posted its quarterly earnings data on Tuesday, August, 6th. The company reported ($0.07) EPS for the quarter, hitting analysts' consensus estimates of ($0.07). The company's revenue for the quarter was up 38.7% compared to the same quarter last year.

agilon health (AGL) raised $1 billion in an initial public offering (IPO) on Thursday, April 15th 2021. The company issued 46,600,000 shares at a price of $20.00-$23.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Deutsche Bank Securities and Wells Fargo Securities acted as the underwriters for the IPO and William Blair, Truist Securities and Nomura were co-managers.

Top institutional investors of agilon health include AQR Capital Management LLC (0.33%), Bank of New York Mellon Corp (0.27%), Susquehanna Fundamental Investments LLC (0.20%) and Rhumbline Advisers (0.11%). Insiders that own company stock include Cd&R Investment Associates Ix,, Veeral Desai, Benjamin Shaker, Steven Sell, Benjamin Kornitzer, Jeffrey A Schwaneke, Timothy Gertsch, Michael L Smith, John William Wulf, Joan Danieley, Theodore Halkias and Glenn Sobotka.
View institutional ownership trends
.

Shares of AGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

Last Earnings
8/06/2024
Today
9/20/2024
Next Earnings (Estimated)
11/07/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
Healthcare
Fax
N/A
Employees
1,117
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$8.57
High Stock Price Target
$18.00
Low Stock Price Target
$4.00
Potential Upside/Downside
+129.1%
Consensus Rating
Hold
Rating Score (0-4)
2.16
Research Coverage
19 Analysts

Profitability

Net Income
$-262,600,000.00
Pretax Margin
-4.01%

Debt

Sales & Book Value

Annual Sales
$5.28 billion
Book Value
$1.63 per share

Miscellaneous

Free Float
398,102,000
Market Cap
$1.54 billion
Optionable
Not Optionable
Beta
0.54
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

This page (NYSE:AGL) was last updated on 9/20/2024 by MarketBeat.com Staff
From Our Partners